THE EFFECT OF PORCINE OREXIN A ON GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE PLASMA CONCENTRATIONS IN PIGS

被引:6
|
作者
Papakonstantinou, P. [1 ]
Tziris, N. [1 ]
Kapoukranidou, D.
Gotzamani-Psarrakou, A. [2 ]
Tsonidis, C. H. R. [3 ]
Patsikas, M. N. [4 ]
Papazoglou, G. [4 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Surg Clin 3, GR-54006 Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Dept Psychol, Sch Med, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Dept Nucl Med, GR-54006 Thessaloniki, Greece
[4] Aristotle Univ Thessaloniki, Dept Clin Sci, Neurosurg Clin 2, GR-54006 Thessaloniki, Greece
关键词
Orexin A; GIP; gastrointestinal (or gut) hormones; i.c.v injection; enteroinsular axis; brain-gut axis; NEURONS; RELEASE;
D O I
10.1177/1721727X1000800103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The orexigenic system was discovered in 1998. It consists of two neuropeptides, Orexin A and Orexin B. Researchers have focused more on Orexin A, since its intracerebroventricular injection into the lateral ventricle of the rat's brain causes an increase in the consumption of food. Besides, it seems that, apart from appetite, Orexin A regulates many other physiological functions with unknown regulatory and metabolic mechanisms. Orexin A is produced by a small group of neurons located in and around the lateral hypothalamic area. It has been known for decades that the latter is involved in regulating feeding in mammals. An intravenous injection of Orexin A causes changes in insulin and glucagon plasma concentrations in rats. In this study, we investigated the possible effects of the central administration of porcine Orexin A on glucose-dependent insulinotropic polypeptide plasma concentrations in pigs, and examined whether these changes are related to the possible effect of the neuropeptide on the enteroinsular axis.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [1] THE PHARMACOKINETICS OF PORCINE GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) IN MAN
    SARSON, DL
    HAYTER, RC
    BLOOM, SR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (06) : 457 - 461
  • [2] Glucose-dependent insulinotropic polypeptide (GIP)
    Mueller, Timo D.
    Adriaenssens, Alice
    Ahren, Bo
    Blueher, Matthias
    Birkenfeld, Andreas L.
    Campbell, Jonathan E.
    Coghlan, Matthew P.
    D'Alessio, David
    Deacon, Carolyn F.
    Delprato, Stefano
    Douros, Jonathan D.
    Drucker, Daniel J.
    Burgos, Natalie S. Figueredo
    Flatt, Peter R.
    Finan, Brian
    Gimeno, Ruth E.
    Gribble, Fiona M.
    Hayes, Matthew R.
    Hoelscher, Christian
    Holst, Jens J.
    Knerr, Patrick J.
    Knop, Filip K.
    Kusminski, Christine M.
    Liskiewicz, Arkadiusz
    Mabilleau, Guillaume
    Mowery, Stephanie A.
    Nauck, Michael A.
    Novikoff, Aaron
    Reimann, Frank
    Roberts, Anna G.
    Rosenkilde, Mette M.
    Samms, Ricardo J.
    Scherer, Philip E.
    Seeley, Randy J.
    Sloop, Kyle W.
    Wolfrum, Christian
    Wootten, Denise
    Dimarchi, Richard D.
    Tschoep, Matthias H.
    MOLECULAR METABOLISM, 2025, 95
  • [3] Identification of plasma binding proteins for glucose-dependent insulinotropic polypeptide
    Hoshiyama, Ayako
    Fujimoto, Kazumi
    Konno, Ryo
    Sasaki, Sayaka
    Momozono, Akari
    Kodera, Yoshio
    Shichiri, Masavoshi
    ENDOCRINE JOURNAL, 2019, 66 (07) : 621 - 628
  • [4] The rate of intestinal glucose absorption is correlated with plasma glucose-dependent insulinotropic polypeptide concentrations in healthy men
    Wachters-Hagedoorn, Renate E.
    Priebe, Marion G.
    Heimweg, Janneke A. J.
    Heiner, A. Marius
    Englyst, Klaus N.
    Holst, Jens. J.
    Stellaard, Frans
    Vonk, Roel J.
    JOURNAL OF NUTRITION, 2006, 136 (06): : 1511 - 1516
  • [5] THE EFFECT OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE INFUSED AT PHYSIOLOGICAL CONCENTRATIONS ON THE RELEASE OF INSULIN IN MAN
    SARSON, DL
    WOOD, SM
    HOLDER, D
    BLOOM, SR
    DIABETOLOGIA, 1982, 22 (01) : 33 - 36
  • [6] Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide
    Meier, JJ
    Nauck, MA
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 587 - 606
  • [7] Effects of somatostatin-28 on plasma glucose-dependent insulinotropic polypeptide and serum insulin concentrations
    Faulkner, A
    Martin, PA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) : S544 - S544
  • [8] Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP) - Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat
    Tseng, CC
    Kieffer, TJ
    Jarboe, LA
    Usdin, TB
    Wolfe, MM
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11): : 2440 - 2445
  • [9] Expression of glucose-dependent insulinotropic polypeptide in the zebrafish
    Musson, Michelle C.
    Jepeal, Lisa I.
    Mabray, Patrick D.
    Zhdanova, Irina V.
    Cardoso, Wellington V.
    Wolfe, M. Michael
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 297 (06) : R1803 - R1812
  • [10] Effects of glucose-dependent insulinotropic polypeptide on glucagon
    Christensen, Mikkel
    Knop, Filip K.
    CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (03): : 75 - 81